Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17511851 | 0.95 | ALDH1A1 (0.34) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL525030 | 0.79 | NPC1 (0.46) | ALDH1A1MAPT | |
| SCHEMBL1094981 | 0.77 | ALDH1A1 (0.50) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL29994991 | 0.77 | ALDH1A1 (0.50) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL1044235 | 0.77 | ALDH1A1 (0.32) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL756551 | 0.77 | CYP2A6 (0.32) | — | |
| SCHEMBL15124859 | 0.75 | ALDH1A1 (0.48) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL15124134 | 0.75 | ALDH1A1 (0.48) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL17511883 | 0.75 | NPC1 (0.46) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL18832 | 0.75 | ALDH1A1 (0.36) | ALDH1A1GLAMAPTHPGDACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012013310-A1 | POLYMERS CONTAINING SUBSTITUTED BENZODITHIOPHENE UNITS, BLENDS CONTAINING SAID POLYMERS, AND DEVICES CONTAINING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2012-02-02 | — | — | WO | claimed |
| WO-2010149258-A1 | POLYMERS COMPRISING SUBSTITUTED ANTHRACENYL UNITS, BLENDS COMPRISING SAID POLYMERS, AND DEVICE COMPRISING SAID POLYMERS OR BLENDS | MERCK PATENT GMBH (DE) | 2010-12-29 | — | — | WO | claimed |
| US-9780310-B2 | Heterocyclic compound for organic electroluminescent device and its application | TOSOH CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20160056388-A1 | HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION | TOSOH CORPORATION (JP) | 2016-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160056388-A1 | HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION | AOC2, AZI2, KCNH2 | ALDH1A1 448/4885GLA 790/4885MAPT 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.